The Institute for Systems Biology, an independent, non-profit
biomolecular research institute, has received a $6 million gift from a
California venture capitalist and philanthropist to support strategic
organizational objectives.
“Government funding and industry
collaborations succeed in advancing science, to be sure”
The donor, who wishes to remain anonymous, is designating his gift over
a period of five years to:
-
facilitate ISB’s move to a new building that will double space for
research and core technology facilities;
-
recruit additional faculty; and
-
provide unrestricted support for research in areas including P4
medicine, biofuels, and global health, and for transferring new
knowledge to society.
The gift comes on the heels of an international report from the
Spain-based Scimago Research Group that found ISB research papers have
the highest scientific impact in the United States and the third highest
in the world. The report analyzed the impact of scientific papers
published by more than 2000 research institutes around the globe between
2003 and 2007. Reviewed institutions represent 84 countries and five
continents.
“This outstanding philanthropic leadership provides critical support for
truly revolutionary advances in science,” said Lee Hood, MD, PhD,
co-founder and president of ISB. “Government funding and industry
collaborations succeed in advancing science, to be sure,” Hood said,
“but that funding is often restricted to the support of highly
prescribed research programs focused on incremental advances.”
“Visionary donors such as this wonderful friend of ISB understand the
importance of unrestricted support in the pursuit of scientific ideas
that can literally change the world. We are truly grateful,” Hood said.
When launched 10 years ago, ISB was in and of itself a revolutionary
concept. It was the first institute in the world dedicated to using
systems approaches to unravel complex biological systems, generating
knowledge that would enable physicians to diagnose and treat disease
prior to the development of symptoms, and some day, prevent disease from
occurring at all.
“When we launched ISB the scientific community was skeptical of the
approach and of enabling biologists, technologists, physicists,
mathematicians, computer scientists, geneticists and others to work side
by side to solve biological problems,” Hood said. “Now practically every
elite academic institution in the US is using systems approaches, and
scientists around the globe look to our research when conducting their
own.”
“This gift strengthens ISB’s ability to continue changing the world.”